Search
Search Results
##search.searchResults.foundPlural##
-
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
896PDF: 154HTML: 226 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
830PDF: 936PDF Supp. Files: 105HTML: 259 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1413PDF: 570HTML: 304 -
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1754PDF: 1057HTML: 1896Untitled: 235Untitled: 218 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2638PDF: 895HTML: 9065Efremov 1: 269Efremov 2: 237 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2955PDF: 1210HTML: 11425 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2701PDF: 932HTML: 17604Fig1 Caligaris: 219Fig.2 Caliga: 268 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1504PDF: 1317HTML: 522 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1502PDF: 876HTML: 3144 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1732PDF: 691HTML: 2448 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1182PDF: 1229Suppl. Files: 595HTML: 101 -
IMMUNOLOGY OF TUBERCULOSIS
5841PDF: 2211HTML: 7367Untitled: 239 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1298PDF: 648HTML: 2914ATRA induced Reactive Hemophagocytosis: A Case Report: 236 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3752PDF: 2619HTML: 1657 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3217PDF: 943HTML: 7312Kost Fig1: 225Kost Fig 2: 212Kost Fig3: 226Kost Fig 4: 238Kost Fig5: 233Kost fig 6: 216 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1880PDF: 630HTML: 364 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1431PDF: 495HTML: 18630Figure 1: 201Figure 2: 185Figure 3: 197Figure 4: 230Figure 5: 205 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1536PDF: 992HTML: 259 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2694PDF: 861HTML: 5383 -
RECENT ADVANCES IN THE 5Q- SYNDROME
3026PDF: 1917HTML: 3825Pellagatti Fig 1: 262Pellagatti Fig. 2: 249 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3389PDF: 1543HTML: 5972Fig1-Ag-Pil: 280Ag-Pil Fig.2: 279 -
-
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3112PDF: 928HTML: 6619Untitled: 276Untitled: 236Untitled: 251Untitled: 261 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2098PDF: 1730HTML: 808 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2608PDF: 1257HTML: 1087 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2636PDF: 1783HTML: 672 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5050PDF: 2963HTML: 2356 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4080PDF: 1114HTML: 3903Untitled: 198Cneo. Fig.1: 140Untitled: 131Untitled: 156Untitled: 167 -
-
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2389PDF: 1114HTML: 2030Characteristic of study group: 237 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2359PDF: 931HTML: 2020Fig 1 Rossi: 241 -
-
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3312PDF: 1166HTML: 1959 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1337PDF: 561HTML: 23219 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3400PDF: 993HTML: 3656 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
1104PDF: 521HTML: 162







